{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:50:42Z","timestamp":1787205042658,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-023-09135-4","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T13:02:08Z","timestamp":1705410128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u201cCombination treatments of imatinib with astaxanthin and crocin efficiently ameliorate antioxidant status, inflammation and cell death progression in imatinib-resistant chronic myeloid leukemia cells\u201d"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-0845","authenticated-orcid":false,"given":"Amin","family":"Golestani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3655-5692","authenticated-orcid":false,"given":"Atefeh","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4802-8147","authenticated-orcid":false,"given":"Mahsa","family":"Najafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3087-705X","authenticated-orcid":false,"given":"Mahtab","family":"Sayadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7458-7711","authenticated-orcid":false,"given":"Seyed Mehdi","family":"Sajjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"9135_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1634\/theoncologist.2015-0337","volume":"21","author":"S Soverini","year":"2016","unstructured":"Soverini S, De Benedittis C, Mancini M, Martinelli G (2016) Best practices in chronic Myeloid Leukemia monitoring and management. Oncologist 21:626\u2013633","journal-title":"Oncologist"},{"key":"9135_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/ptr.6355","volume":"33","author":"H Cai","year":"2019","unstructured":"Cai H, Li L, Jiang J, Zhao C, Yang C (2019) Costunolide enhances sensitivity of K562\/ADR chronic Myeloid Leukemia cells to doxorubicin through PI3K\/Akt pathway. Phytother Res 33:1683\u20131688. https:\/\/doi.org\/10.1002\/ptr.6355","journal-title":"Phytother Res"},{"key":"9135_CR3","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/ptr.6968","volume":"35","author":"M Zhao","year":"2021","unstructured":"Zhao M, Yang C, Chai S, Yuan Y, Zhang J, Cao P, Wang Y, Xiao X, Wu K, Yan H, Liu J, Sun S (2021) Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic Leukemia via multiple signaling pathways. Phytother Res 35:2157\u20132170. https:\/\/doi.org\/10.1002\/ptr.6968","journal-title":"Phytother Res"},{"key":"9135_CR4","doi-asserted-by":"publisher","first-page":"e102221","DOI":"10.1371\/journal.pone.0102221","volume":"9","author":"Y Kang","year":"2014","unstructured":"Kang Y, Hodges A, Ong E, Roberts W, Piermarocchi C, Paternostro G (2014) Identification of drug combinations containing imatinib for treatment of BCR-ABL\u2009+\u2009leukemias. PLoS ONE 9:e102221","journal-title":"PLoS ONE"},{"key":"9135_CR5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3109\/10428194.2013.845883","volume":"55","author":"EJ Jabbour","year":"2014","unstructured":"Jabbour EJ, Hughes TP, Cort\u00e9s JE, Kantarjian HM, Hochhaus A (2014) Potential mechanisms of Disease progression and management of advanced-phase chronic Myeloid Leukemia. Leuk Lymphoma 55:1451\u20131462","journal-title":"Leuk Lymphoma"},{"key":"9135_CR6","doi-asserted-by":"publisher","first-page":"7521","DOI":"10.1007\/s11033-022-07560-5","volume":"49","author":"M Yenig\u00fcl","year":"2022","unstructured":"Yenig\u00fcl M, Ak\u00e7ok \u0130, Gencer Ak\u00e7ok EB (2022) Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic Myeloid Leukemia cells. Mol Biol Rep 49:7521\u20137530","journal-title":"Mol Biol Rep"},{"key":"9135_CR7","doi-asserted-by":"publisher","unstructured":"Abdulmawjood B, Roma-Rodrigues C, Baptista PV, Fernandes AR, Particle (2023) & Particle Systems Characterization. https:\/\/doi.org\/10.1002\/ppsc.202300090","DOI":"10.1002\/ppsc.202300090"},{"key":"9135_CR8","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/molecules28031210","volume":"28","author":"R Alves","year":"2023","unstructured":"Alves R, Santos D, Jorge J, Gon\u00e7alves AC, Catarino S, Gir\u00e3o H, Melo JB, Sarmento-Ribeiro AB (2023) Alvespimycin inhibits heat shock protein 90 and overcomes Imatinib Resistance in Chronic Myeloid Leukemia cell lines. Molecules 28:1210","journal-title":"Molecules"},{"key":"9135_CR9","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2015.014","author":"IC Haznedaroglu","year":"2015","unstructured":"Haznedaroglu IC (2015) Drug therapy in the progressed CML patient with multi-TKI failure. Mediterranean J Hematol Infect Dis. https:\/\/doi.org\/10.4084\/MJHID.2015.014","journal-title":"Mediterranean J Hematol Infect Dis"},{"key":"9135_CR10","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/ijms24032356","volume":"24","author":"G Feriotto","year":"2023","unstructured":"Feriotto G, Marchetti P, Rondanin R, Tagliati F, Aguzzi S, Beninati S, Casciano F, Tabolacci C, Mischiati C (2023) Cytotoxicity of Isoxazole Curcumin analogs on chronic myeloid leukemia-derived K562 cell lines sensitive and resistant to Imatinib. Int J Mol Sci 24:2356","journal-title":"Int J Mol Sci"},{"key":"9135_CR11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3389\/fonc.2021.664380","volume":"11","author":"MZ Saavedra-Leos","year":"2021","unstructured":"Saavedra-Leos MZ, Jordan-Alejandre E, L\u00f3pez-Camarillo C, Pozos-Guillen A, Leyva-Porras C, Silva-C\u00e1zares MB (2021) Nanomaterial complexes enriched with natural compounds used in Cancer therapies: a perspective for clinical application. Front Oncol 11:1032. https:\/\/doi.org\/10.3389\/fonc.2021.664380","journal-title":"Front Oncol"},{"key":"9135_CR12","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1002\/ptr.6422","volume":"33","author":"O Wattanathamsan","year":"2019","unstructured":"Wattanathamsan O, Hayakawa Y, Pongrakhananon V (2019) Molecular mechanisms of natural compounds in cell death induction and sensitization to chemotherapeutic Drugs in Lung cancer. Phytother Res 33:2531\u20132547. https:\/\/doi.org\/10.1002\/ptr.6422","journal-title":"Phytother Res"},{"key":"9135_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijbiomac.2022.02.113","volume":"206","author":"S Kheyrandish","year":"2022","unstructured":"Kheyrandish S, Rastgar A, Hamidi M, Sajjadi SM, Sarab GA (2022) Evaluation of anti-tumor effect of the exopolysaccharide from new cold-adapted yeast, Rhodotorula mucilaginosa sp. GUMS16 on chronic Myeloid Leukemia K562 cell line. Int J Biol Macromol 206:21\u201328","journal-title":"Int J Biol Macromol"},{"key":"9135_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s11033-021-06141-2","volume":"48","author":"T Ozkan","year":"2021","unstructured":"Ozkan T, Hekmatshoar Y, Pamuk H, Ozcan M, Yaman G, Yagiz GC, Akdemir C, Sunguroglu A (2021) Cytotoxic effect of 6-Shogaol in Imatinib sensitive and resistant K562 cells. Mol Biol Rep 48:1625\u20131631","journal-title":"Mol Biol Rep"},{"key":"9135_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11033-021-06778-z","volume":"49","author":"R Saraei","year":"2022","unstructured":"Saraei R, Rahman HS, Soleimani M, Asghari-Jafarabadi M, Naimi A, Hassanzadeh A, Solali S (2022) Kaempferol sensitizes Tumor necrosis factor-related apoptosis-inducing ligand-resistance chronic myelogenous Leukemia cells to apoptosis. Mol Biol Rep 49:19\u201329","journal-title":"Mol Biol Rep"},{"key":"9135_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11094-022-02627-w","volume":"56","author":"A Talebpour","year":"2022","unstructured":"Talebpour A, Alipour R, Sajjadi SM, Osmani F, Sarab GA (2022) In Vitro cytotoxicity of Ferula Asafoetida Gum extract on human chronic myelogenous Leukemia K562 cells. Pharm Chem J 56:245\u2013253","journal-title":"Pharm Chem J"},{"key":"9135_CR17","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.3390\/molecules26175152","volume":"26","author":"E Binatti","year":"2021","unstructured":"Binatti E, Zoccatelli G, Zanoni F, Don\u00e0 G, Mainente F, Chignola R (2021) Effects of Combination treatments with astaxanthin-loaded microparticles and pentoxifylline on intracellular ROS and radiosensitivity of J774A. 1 macrophages. Molecules 26:5152","journal-title":"Molecules"},{"key":"9135_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijbiomac.2022.02.057","volume":"205","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xu Y, Wu S, Zheng W, Song S, Ai C (2022) Fabrication of astaxanthin-enriched colon-targeted alginate microspheres and its beneficial effect on dextran sulfate sodium-induced ulcerative Colitis in mice. Int J Biol Macromol 205:396\u2013409. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.02.057","journal-title":"Int J Biol Macromol"},{"key":"9135_CR19","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1002\/ptr.6514","volume":"33","author":"T Brendler","year":"2019","unstructured":"Brendler T, Williamson EM (2019) Astaxanthin: how much is too much? A safety review. Phytother Res 33:3090\u20133111","journal-title":"Phytother Res"},{"key":"9135_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.07.037","volume":"186","author":"H Rajabi","year":"2021","unstructured":"Rajabi H, Jafari SM, Feizi J, Ghorbani M, Mohajeri SA (2021) Surface-decorated graphene oxide sheets with nanoparticles of chitosan-arabic gum for the separation of bioactive compounds: a case study for adsorption of crocin from saffron extract. Int J Biol Macromol 186:1\u201312","journal-title":"Int J Biol Macromol"},{"key":"9135_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.fct.2014.09.001","volume":"74","author":"GD Geromichalos","year":"2014","unstructured":"Geromichalos GD, Papadopoulos T, Sahpazidou D, Sinakos Z (2014) Safranal, a Crocus sativus L constituent suppresses the growth of K-562 cells of chronic myelogenous Leukemia. In silico and in vitro study. Food Chem Toxicol 74:45\u201350","journal-title":"Food Chem Toxicol"},{"key":"9135_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/690164","author":"Y Sun","year":"2013","unstructured":"Sun Y, Xu H-J, Zhao Y-X, Wang L-Z, Sun L-R, Wang Z, Sun X-F (2013) Crocin exhibits antitumor effects on human Leukemia HL-60 cells in vitro and in vivo. Evidence-Based Complement Altern Med. https:\/\/doi.org\/10.1155\/2013\/690164","journal-title":"Evidence-Based Complement Altern Med \u2022"},{"key":"9135_CR23","doi-asserted-by":"publisher","DOI":"10.17795\/jjnpp-20131","author":"R Rezaee","year":"2014","unstructured":"Rezaee R, Jamialahmadi K, Zanjani BR, Mahmoudi M, Abnous K, Rabe SZT, Tabasi N, Zali M, Rezaee M, Amin B (2014) Crocin effects on human Myeloma cells regarding intracellular redox state, DNA fragmentation, and apoptosis or necrosis profile. Jundishapur J Nat Pharm Prod. https:\/\/doi.org\/10.17795\/jjnpp-20131","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"9135_CR24","doi-asserted-by":"publisher","unstructured":"Shahraki S, Bahraini F, Mesbahzadeh B, Sayadi M, Sajjadi SM (2023) Glucose increases proliferation and chemoresistance in chronic Myeloid Leukemia via decreasing antioxidant properties of \u03c9-3 polyunsaturated fatty acids in the presence of Iron. Mol Biol Rep 1\u201310. https:\/\/doi.org\/10.1007\/s11033-023-08891-7","DOI":"10.1007\/s11033-023-08891-7"},{"key":"9135_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"T-C Chou","year":"2010","unstructured":"Chou T-C (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70:440\u2013446","journal-title":"Cancer Res"},{"key":"9135_CR26","doi-asserted-by":"publisher","unstructured":"Elzaawely A, Tawata S (2012) Antioxidant activity of phenolic rich fraction obtained from Convolvulus arvensis L. leaves grown in Egypt. Asian J Crop Sci. https:\/\/doi.org\/10.3923\/ajcs.2012.32.40","DOI":"10.3923\/ajcs.2012.32.40"},{"key":"9135_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. Methods 25:402\u2013408","journal-title":"Methods"},{"issue":"46","key":"9135_CR28","doi-asserted-by":"publisher","first-page":"e2111451118","DOI":"10.1073\/pnas.2111451118","volume":"118","author":"A Lyczek","year":"2021","unstructured":"Lyczek A, Berger B-T, Rangwala AM, Paung Y, Tom J, Philipose H, Guo J, Albanese SK, Robers MB, Knapp S (2021) Mutation in abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance. Proc Natl Acad Sci 118(46):e2111451118. https:\/\/doi.org\/10.1073\/pnas.2111451118","journal-title":"Proc Natl Acad Sci"},{"key":"9135_CR29","first-page":"970","volume":"1","author":"KM Kirschner","year":"2003","unstructured":"Kirschner KM, Baltensperger K (2003) Erythropoietin promotes Resistance against the abl tyrosine kinase inhibitor Imatinib (STI571) in K562 Human Leukemia Cells11Swiss National Science Foundation grant 31-059124 and Swiss Cancer League grant SKL 778-2-1999. Note: current address of Dr. Karin M. Kirschner is at Johannes-M\u00fcller Institut fu\u0307r Physiologie, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Charit\u00e9-Mitte, Tucholskystrasse 2, 10117 Berlin. Ger Mol cancer Res 1:970\u2013980","journal-title":"Ger Mol cancer Res"},{"key":"9135_CR30","doi-asserted-by":"publisher","first-page":"2244856","DOI":"10.1080\/16078454.2023.2244856","volume":"28","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhong F, Jiang J, Li M, Yao F, Liu J, Cheng Y, Xu S, Chen S, Zhang H (2023) Bioinformatic analysis of the expression profile and identification of RhoGDI2 as a biomarker in imatinib-resistant K562 cells. Hematology 28:2244856","journal-title":"Hematology"},{"key":"9135_CR31","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/antiox9060532","volume":"9","author":"J Shin","year":"2020","unstructured":"Shin J, Song M-H, Oh J-W, Keum Y-S, Saini RK (2020) Pro-oxidant actions of carotenoids in triggering apoptosis of cancer cells: a review of emerging evidence. Antioxidants 9:532","journal-title":"Antioxidants"},{"key":"9135_CR32","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1007\/s11033-022-07452-8","volume":"49","author":"A Rastgar","year":"2022","unstructured":"Rastgar A, Sayadi M, Anani-Sarab G, Sajjadi SM (2022) Astaxanthin decreases the growth-inhibitory dose of cytarabine and inflammatory response in the acute lymphoblastic Leukemia cell line NALM-6. Mol Biol Rep 49:6415\u20136422","journal-title":"Mol Biol Rep"},{"key":"9135_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.toxlet.2013.06.233","volume":"221","author":"X Li","year":"2013","unstructured":"Li X, Huang T, Jiang G, Gong W, Qian H, Zou C (2013) Synergistic apoptotic effect of crocin and cisplatin on osteosarcoma cells via caspase induced apoptosis. Toxicol Lett 221:197\u2013204","journal-title":"Toxicol Lett"},{"issue":"4","key":"9135_CR34","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/molecules23040905","volume":"23","author":"X Gong","year":"2018","unstructured":"Gong X, Smith JR, Swanson HM, Rubin LP (2018) Carotenoid lutein selectively inhibits Breast cancer cell growth and potentiates the effect of chemotherapeutic agents through ROS-mediated mechanisms. Molecules 23(4):905. https:\/\/doi.org\/10.3390\/molecules23040905","journal-title":"Molecules"},{"issue":"3","key":"9135_CR35","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.18632\/oncotarget.13882","volume":"8","author":"JL Rausch","year":"2017","unstructured":"Rausch JL, Boichuk S, Ali AA, Patil SS, Lee DM, Brown MF, Makielski KR, Liu Y, Taguchi T, Kuan S-F (2017) Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal Tumor (GIST) cells to imatinib mesylate. Oncotarget 8(3):4471\u20134483","journal-title":"Oncotarget"},{"key":"9135_CR36","doi-asserted-by":"publisher","first-page":"133141","DOI":"10.1016\/j.molstruc.2022.133141","volume":"1263","author":"MI El-Barghouthi","year":"2022","unstructured":"El-Barghouthi MI, Hasan AS, Al-Awaida W, Al-Ameer HJ, Kaur J, Hayashibara KJ, Fleming J, Waknin J, Hayashibara S, Slewa M (2022) Novel therapeutic heterocycles as selective cyclooxygenase-2 inhibitors and anti-cancer agents: synthesis, in vitro bioassay screenings, and molecular docking studies. J Mol Struct 1263:133141","journal-title":"J Mol Struct"},{"key":"9135_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","volume":"108","author":"M Koptyra","year":"2006","unstructured":"Koptyra M, Falinski R, Nowicki MO, Stoklosa T, Majsterek I, Nieborowska-Skorska M, Blasiak J, Skorski T (2006) BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 108:319\u2013327","journal-title":"Blood"},{"key":"9135_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1089\/biores.2015.0022","volume":"4","author":"J Blasiak","year":"2015","unstructured":"Blasiak J, Hoser G, Bialkowska-Warzecha J, Pawlowska E, Skorski T (2015) Reactive oxygen species and mitochondrial DNA damage and repair in BCR-ABL1 cells resistant to imatinib. BioResearch open Access 4:334\u2013342","journal-title":"BioResearch open Access"},{"key":"9135_CR39","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1021\/acs.jafc.7b05493","volume":"66","author":"T Niu","year":"2018","unstructured":"Niu T, Xuan R, Jiang L, Wu W, Zhen Z, Song Y, Hong L, Zheng K, Zhang J, Xu Q (2018) Astaxanthin induces the Nrf2\/HO-1 antioxidant pathway in human umbilical vein endothelial cells by generating trace amounts of ROS. J Agric Food Chem 66:1551\u20131559","journal-title":"J Agric Food Chem"},{"key":"9135_CR40","doi-asserted-by":"publisher","first-page":"110713","DOI":"10.1016\/j.biopha.2020.110713","volume":"131","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zheng B, Li J, Shi J, Chu L, Han X, Chu X, Zhang X, Zhang J (2020) Crocin ameliorates arsenic trioxide\u2013induced cardiotoxicity via Keap1-Nrf2\/HO-1 pathway: reducing oxidative stress, inflammation, and apoptosis. Biomed Pharmacother 131:110713. https:\/\/doi.org\/10.1016\/j.biopha.2020.110713","journal-title":"Biomed Pharmacother"},{"key":"9135_CR41","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3389\/fphar.2018.01536","volume":"9","author":"L Staurengo-Ferrari","year":"2019","unstructured":"Staurengo-Ferrari L, Badaro-Garcia S, Hohmann MS, Manchope MF, Zaninelli TH, Casagrande R, Verri WA Jr (2019) Contribution of Nrf2 modulation to the mechanism of action of analgesic and anti-inflammatory Drugs in pre-clinical and clinical stages. Front Pharmacol 9:1536","journal-title":"Front Pharmacol"},{"key":"9135_CR42","doi-asserted-by":"publisher","first-page":"111374","DOI":"10.1016\/j.biopha.2021.111374","volume":"137","author":"Z Kohandel","year":"2021","unstructured":"Kohandel Z, Farkhondeh T, Aschner M, Samarghandian S (2021) Nrf2 a molecular therapeutic target for Astaxanthin. Biomed Pharmacother 137:111374","journal-title":"Biomed Pharmacother"},{"key":"9135_CR43","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ptr.6564","volume":"34","author":"C Godugu","year":"2020","unstructured":"Godugu C, Pasari LP, Khurana A, Anchi P, Saifi MA, Bansod SP, Annaldas S (2020) Crocin, an active constituent of Crocus sativus ameliorates cerulein induced pancreatic inflammation and oxidative stress. Phytother Res 34:825\u2013835. https:\/\/doi.org\/10.1002\/ptr.6564","journal-title":"Phytother Res"},{"key":"9135_CR44","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1158\/1535-7163.MCT-08-0314","volume":"7","author":"NN Bewry","year":"2008","unstructured":"Bewry NN, Nair RR, Emmons MF, Boulware D, Pinilla-Ibarz J, Hazlehurst LA (2008) Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance. Mol Cancer Ther 7:3169\u20133175","journal-title":"Mol Cancer Ther"},{"key":"9135_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.leukres.2013.11.012","volume":"38","author":"D Sayed","year":"2014","unstructured":"Sayed D, Badrawy H, Gaber N, Khalaf MR (2014) p-Stat3 and bcr\/abl gene expression in chronic Myeloid Leukemia and their relation to imatinib therapy. Leuk Res 38:243\u2013250. https:\/\/doi.org\/10.1016\/j.leukres.2013.11.012","journal-title":"Leuk Res"},{"issue":"9","key":"9135_CR46","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3324\/haematol.2016.163436","volume":"102","author":"KV Gleixner","year":"2016","unstructured":"Gleixner KV, Schneeweiss MA, Herrmann H, Blatt K, Berger D, Eisenwort G, Greiner G, Byrgazov K, Hoermann G, Konopleva M (2016) Combined targeting of STAT3 and STAT5: a Novel Approach to Overcome Drug Resistance in Ph\u2009+\u2009cml. Haematologica 102(9):1519\u20131529. https:\/\/doi.org\/10.3324\/haematol.2016.163436","journal-title":"Haematologica"},{"issue":"1","key":"9135_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41420-023-01700-x","volume":"9","author":"MB Gayatri","year":"2023","unstructured":"Gayatri MB, Kancha RK, Behera A, Patchva D, Velugonda N, Gundeti S, Reddy ABM (2023) AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous Leukemia (CML) subjects. Cell Death Discovery 9(1):401. https:\/\/doi.org\/10.1038\/s41420-023-01700-x","journal-title":"Cell Death Discovery"},{"key":"9135_CR48","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/leu.2014.245","volume":"29","author":"AM Eiring","year":"2015","unstructured":"Eiring AM, Page BD, Kraft IL, Mason CC, Vellore NA, Resetca D, Zabriskie MS, Zhang TY, Khorashad JS, Engar AJ (2015) Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic Myeloid Leukemia. Leukemia 29:586\u2013597","journal-title":"Leukemia"},{"key":"9135_CR49","first-page":"1","volume":"8","author":"JH Han","year":"2018","unstructured":"Han JH, Ju JH, Lee YS, Park JH, Yeo IJ, Park MH, Roh YS, Han SB, Hong JT (2018) Astaxanthin alleviated ethanol-induced liver injury by inhibition of oxidative stress and inflammatory responses via blocking of STAT3 activity. Sci Rep 8:1\u201310","journal-title":"Sci Rep"},{"key":"9135_CR50","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10126-019-09904-y","volume":"21","author":"CM Messina","year":"2019","unstructured":"Messina CM, Manuguerra S, Renda G, Santulli A (2019) Biotechnological applications for the sustainable use of marine by-products: in vitro antioxidant and pro-apoptotic effects of astaxanthin extracted with supercritical co2 from Parapeneus Longirostris. Mar Biotechnol 21:565\u2013576","journal-title":"Mar Biotechnol"},{"issue":"131","key":"9135_CR51","doi-asserted-by":"publisher","first-page":"e2021049","DOI":"10.4084\/MJHID.2021.049","volume":"1","author":"AS Jahromi","year":"2021","unstructured":"Jahromi AS, Kargar M, Kafilzadeh F, Jamalidoust M, Moradzadeh M (2021) Crocin promotes apoptosis in human EBV-transformed B-lymphocyte via intrinsic pathway. Mediterranean J Hematol Infect Dis 1(131):e2021049. https:\/\/doi.org\/10.4084\/MJHID.2021.049","journal-title":"Mediterranean J Hematol Infect Dis"},{"key":"9135_CR52","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/21691401.2019.1580286","volume":"47","author":"M Hormozi","year":"2019","unstructured":"Hormozi M, Ghoreishi S, Baharvand P (2019) Astaxanthin induces apoptosis and increases activity of antioxidant enzymes in LS-180 cells. Artif Cells Nanomed Biotechnol 47:891\u2013895","journal-title":"Artif Cells Nanomed Biotechnol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-09135-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:32:05Z","timestamp":1738701125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-09135-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9135"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-09135-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No potential conflict of interest was reported by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of the research and technology deputy of Birjand University of Medical Sciences (IR.BUMS.REC.1399.398).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"108"}}